常山药业：公司正在开展依诺肝素钠注射液在美国市场的销售相关工作

Core Viewpoint - The company is actively working on the sales of Enoxaparin Sodium Injection in the U.S. market, but faces significant uncertainties due to various external factors [2] Group 1: Company Developments - The company is conducting sales-related activities for Enoxaparin Sodium Injection in the U.S. market [2] - The future sales performance of Enoxaparin Sodium Injection in the U.S. is subject to considerable uncertainty due to factors such as changes in overseas market policies, sales channels, exchange rate fluctuations, and market competition [2] - The company will announce any significant progress regarding the transfer of shareholder agreement shares in accordance with relevant regulations [2] Group 2: Regulatory Status - The application for the listing of Abepanelat is still under review, and further developments will be based on publicly available information [2]